A randomized, double blind, placebo-controlled study to investigate the effect of E2007 [perampanel] on pharmacodynamic responses to levodopa among patients with Parkinson's disease who experience dyskinesia and motor fluctuations
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 30 Oct 2013
At a glance
- Drugs Levodopa; Perampanel
- Indications Parkinson's disease
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Eisai Inc
- 10 Sep 2009 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 29 May 2007 New trial record.